An attempt to improve the results of treatment for breast cancer complicated by lysis
G. A. KhakimovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanA. K. MadalimovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanSh. G. KhakimovaTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanKh.I. Dzhumaniyozov DzhumaniyozovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, Uzbekistan
ABI
Annotatsiya
Lysis in locally advanced breast cancer (BC) is not a sign of tumor process dissemination. The correct elaboration of management tactics for such patients may achieve rather good early and late results. The doxorubicin + xeloda regimen for BC complicated by lysis has some advantage over the FAC regimen, without additionally increasing the rate of adverse reactions and worsening the quality of life.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba
Koʻrsatkichlar — AkademScholar · Tez orada